Authors

• Christian Templin (ORCID: https://orcid.org/0000-0003-0287-4193)
• David Niederseer (ORCID: https://orcid.org/0000-0003-3089-1222)
• Arnold von Eckardstein (ORCID: https://orcid.org/0000-0002-1666-2266)
• Jan Gerrit van der Stouwe (ORCID: https://orcid.org/0000-0002-5847-188X)
• Florian A. Wenzl (ORCID: https://orcid.org/0000-0001-6654-9918)
• Lorenz Räber (ORCID: https://orcid.org/0000-0003-0824-3026)
• Christian M. Matter (ORCID: https://orcid.org/0000-0002-8124-1767)
• Simon Kraler (ORCID: https://orcid.org/0000-0002-8245-7287)
• Slayman Obeid (ORCID: https://orcid.org/0000-0002-7672-0923)
• Konstantin Godly
• Julia Godly
• François Mach (ORCID: https://orcid.org/0009-0004-0364-1070)
• Thomas F. Lüscher

Institutions

• University of Leicester (GB)
• King's College London (GB)
• University of Basel (CH)
• University of Zurich (CH)
• University Hospital of Bern (CH)
• University Hospital of Basel (CH)
• Harefield Hospital (GB)
• Karolinska Institutet (SE)
• Kantonsspital Baselland (CH)
• University Hospital of Zurich (CH)
• University Hospital of Geneva (CH)
• CK-CARE (CH)
• Kantonsspital Baden (CH)
• National Cancer Registration Service (GB)
• Hochgebirgsklinik Davos (CH)
• Imperial College London (GB)

Publication Details

Journal

European Journal of Clinical Investigation

Published

2024-09-30

DOI

https://doi.org/10.1111/eci.14314

Citations

7

Primary Topic

Acute Myocardial Infarction Research

Type

article

Field-Weighted Citation Impact

2.81

Funders

• Eli Lilly and Company
• AstraZeneca
• Sanofi
• University of Bern
• Medtronic Europe
• Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
• Schweizerische Herzstiftung
• Merck Sharp and Dohme
• Roche Diagnostics